Condition: Relapsed and/or Refractory B-cell Lymphoma · Sponsor: Kite, A Gilead Company
The goal of this clinical study is to learn more about the safety and effectiveness of the study drugs, KITE-363 and KITE-753, in participants with relapsed and/or refractory B-cell lymphoma.
This description comes directly from the study's public registry record.
Medical Information · 844-454-5483(1-844-454-KITE) · medinfo@kitepharma.com
Always discuss trial participation with your own doctor first.
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | Recruiting |
| City of Hope (City of Hope National Medical Center, City of Hope Medical Center) | Duarte, California, United States | Recruiting |
| Stanford Cancer Institute | Stanford, California, United States | Recruiting |
| Moffitt Cancer Center | Tampa, Florida, United States | Recruiting |
| Northside Hospital | Atlanta, Georgia, United States | Recruiting |
| Midwestern Regional Medical Center, Inc.City of Hope Chicago | Park Ridge, Illinois, United States | Recruiting |
| Norton Cancer Institute, St. Matthews Campus | Shelbyville, Kentucky, United States | Recruiting |
| University of MD, Greenebaum Comprehensive Cancer Center | Baltimore, Maryland, United States | Recruiting |
| Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| Columbia University Irving Medical Center | New York, New York, United States | Recruiting |
| University of Rochester Medical Center | Rochester, New York, United States | Recruiting |
| The Ohio State University Wexner Medical Center - James Cancer Hospital | Columbus, Ohio, United States | Recruiting |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04989803